UGN-101 shows long-term recurrence-free survival benefit in low-grade UTUC

The mitomycin-containing reverse thermal gel UGN-101 (Jelmyto) produced durable responses in patients with low-grade upper tract urothelial carcinoma.

Read the full article here

Related Articles